Robert Wasserman

Hematology | Oncology

610 Schiller Ave
Merion Station, PA 19066

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.

Journal: Science advances

Published: October 06, 2021

Showing 1-1 of 1

Last Updated: 09/26/2026